New biomarker can help detect stomach cancer earlier, study finds

The biomarker MiR130, a microRNA associated with ulcer-causing bacteria Helicobacter pylori can be detected through a blood test and may help identify early cases of gastric cancer, according to a study published in Gut.

Researchers identified the biomarker in mouse models by simulating changes in the stomach similar to those caused by H. pylori, and detected the same microRNA in human patients who had cancer or precancerous changes. 

The biomarker can be detected through blood tests, providing an alternative to the lengthy and invasive process a stomach cancer diagnosis typically requires, according to researchers. 

Researchers also hope the findings can help identify why other gastrointestinal cancers are particularly resistant to treatment therapy. 

Copyright © 2025 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


You can unsubscribe from these communications at any time. For more information, please review our Privacy Policy
.
 

Articles We Think You'll Like

Thank you so much for your interest in our content. Please register to access this complimentary archived content. By registering, you will receive our newsletter which can be opted out of at any time.

 

 

Already Registered? Click here to confirm.